The Institutional Biosafety Committee reviews research involving recombinant DNA, gene transfer, and select biological agents and toxins. This review is mandated by the NIH and is intended to provide local, institutional oversight of nearly all forms of research utilizing recombinant DNA, infectious agents, and other potentially hazardous agents such as carcinogens.
Generally the IBC seeks to review research where:
Institutions that fail to comply, risk the following:
Experiments are exempt when they involve recombinant DNA that is: